HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic Variations and Clinical Features of NPHS1-Related Nephrotic Syndrome in Chinese Children: A Multicenter, Retrospective Study.

Abstract
Introduction: Few studies have addressed the genetic spectrum of NPHS1 variants in Chinese children with nephrotic syndrome. In this multicenter study, the clinical manifestations and features of NPHS1 variants in Chinese children with nephrotic syndrome were researched. Method: Genotypical and phenotypical data from 30 children affected by NPHS1 variants were collected from a multicenter registration system in China and analyzed retrospectively. Results: The patients were divided into two groups: congenital nephrotic syndrome (CNS [n = 24]) and non-CNS (early onset nephrotic syndrome [n = 6]). Renal biopsy was performed on four patients in the non-CNS group, revealing minimal change disease in three and focal segmental glomerulosclerosis in one. A total of 61 NPHS1 variants were detected, involving 25 novel variants. The "recurrent variants" included c.928G>A(p.Asp310Asn) in eight patients with CNS, followed by c.616C>A(p.Pro206Thr) in four, and c.2207T>C (p.Val736Ala) in three. Steroid treatment was applied in 29.2% (7/24)of the patients in the CNS group and 50% (3/6) of the patients in the non-CNS group. One patient in each group experienced complete remission but relapsed subsequently. Immunosuppressants were administered to three patients in the non-CNS group, eliciting an effective response. In the CNS group, three patients underwent renal transplantation and six died mainly from infection. Conclusion: Variants of NPHS1 cause CNS and early childhood-onset nephrotic syndrome. NPHS1 variants in Chinese individuals with nephrotic syndrome (NS) were mainly compound heterozygous variants, and c.928G>A(p.Asp310Asn) in exon 8 may act as a recurrent variant in the Chinese population, followed by c.616C>A(p.Pro206Thr) in exon 6. Steroids and immunosuppressants may be effective in selected patients.
AuthorsLiping Rong, Lizhi Chen, Jia Rao, Qian Shen, Guomin Li, Jialu Liu, Jianhua Mao, Chunyue Feng, Xiaowen Wang, Si Wang, Xinyu Kuang, Wenyan Huang, Qingshan Ma, Xiaorong Liu, Chen Ling, Rong Fu, Xiaojie Gao, Guixia Ding, Huandan Yang, Mei Han, Zhimin Huang, Qian Li, Qiuye Zhang, Yi Lin, Xiaoyun Jiang, Hong Xu
JournalFrontiers in medicine (Front Med (Lausanne)) Vol. 8 Pg. 771227 ( 2021) ISSN: 2296-858X [Print] Switzerland
PMID34859019 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Rong, Chen, Rao, Shen, Li, Liu, Mao, Feng, Wang, Wang, Kuang, Huang, Ma, Liu, Ling, Fu, Gao, Ding, Yang, Han, Huang, Li, Zhang, Lin, Jiang and Xu.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: